Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval.

https://www.forbes.com/sites/amyfeldman/2026/01/12/a-holy-grail-sleep-apnea-pill-could-be-on-the-market-next-year/

#Forbes